SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Galagen(ggen)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Turner who wrote (5)12/4/1997 9:14:00 AM
From: Jonathan Rothschild  Read Replies (1) of 69
 
IMHO, a better value is Immucell (ICCC). They compete with Galagen over similar milk antibody technology and have only 2.3 million shares outstanding without preferred stock or warrants floating around. Galagen had an interesting press release this morning which might make it a more diversified company. I admit that I own a significant stake in Immucell and will now look at possibly accumulating some Galagen shares based on today's patent announcement.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News